Skip to Main Content

Vaccines

The latest stories related to vaccines, including development and production issues.

Latest

Pharma Adam Feuerstein

STAT Plus: GSK buys mRNA-based Covid, flu vaccines from CureVac in restructured partnership

Health Helen Branswell

Moderna receives $176 million from BARDA for mRNA influenza vaccines

Health Helen Branswell

CDC advisory panel opts for a go-slow approach on expanding usage of RSV vaccines

Health Rohan Rajeev

On the road to eliminate rabies deaths, Gavi announces plan to improve human vaccination

The Readout Adam Feuerstein

STAT Plus: A biotech’s binary bet ends badly

The Readout Meghana Keshavan

STAT Plus: FDA offers new guidelines for Covid-19 vaccine

Letters to the editor Patrick Skerrett

Readers respond to a plea for rare disease progress, vaccine-related injury, and more

First Opinion Julie Sweetland

Telling new stories can help people see the value of vaccines

All Coverage

The Readout Meghana Keshavan

The biotech news you missed from the weekend

The Readout Elaine Chen

Novavax will be able to supply Covid-19 vaccines this fall

advertisement

First Opinion Tom Daschle and Kathleen G. Sebelius

Close a regulatory loophole in the ACA to provide vaccine access for all Americans

The Readout Jason Mast

STAT Plus: Testing begins for a new form of PrEP

The Readout Meghana Keshavan

STAT Plus: Can AstraZeneca make good on its promise?

The Readout Elaine Chen

STAT Plus: In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu

The Readout Elaine Chen

STAT Plus: Maryland takes first steps to cap drug costs

Health Helen Branswell

When should we start making H5N1 vaccine, and who will make that decision? In short, it’s complicated

In the Lab Annalisa Merelli and Jonathan Wosen

Animal studies lend support to an innovative HIV vaccine strategy — but there’s still a long way to go

The Readout Meghana Keshavan

AstraZeneca antibody reduced Covid-19 risk in immunocompromised

First Opinion Phyllis Arthur

A dose of reality on adult vaccinations

Biotech Andrew Joseph

STAT Plus: Sanofi enters vaccine licensing deal with Novavax, giving beleaguered biotech a lifeline

Health Annalisa Merelli

A new cholera vaccine will increase supply, but will it be enough to manage global outbreaks?

Health Helen Branswell

Massive amounts of H5N1 vaccine would be needed if there’s a bird flu pandemic. Can we make enough?

The Readout Damian Garde

STAT Plus: What about the company Vertex didn’t buy?

The Readout Damian Garde

STAT Plus: Gas prices are hurting biotech

The Readout Damian Garde

STAT Plus: Pfizer’s plot to win the RSV vaccine race

Health Elizabeth Cooney

STAT Plus: People in Republican-voting states more likely to report Covid-19 vaccine side effects, study says

The Readout Meghana Keshavan

How will the Supreme Court’s mifepristone decision impact biopharma?

Biotech Matthew Herper

STAT Plus: During the pandemic, were great vaccines bad business? A company-by-company review

Health Helen Branswell

RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter: CDC